Compare GSK plc (GSK) vs Sony Group Corp (SONY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Sony Group Corp — how do they compare? GSK plc trades at $52.59 (market cap $101.34B), while Sony Group Corp trades at $21.21 (market cap $123.02B). The key difference: Sony Group Corp is the larger of the two by market cap, and GSK plc pays the higher dividend (3.49%). Which is the better fit depends on your goals.
| GSK | SONY | |
|---|---|---|
Market Cap | $101.34B | $123.02B |
Sector | Health | Technology |
52-Week High | $61.18 | $30.26 |
52-Week Low | $36.20 | $19.32 |
Enterprise Value | $121.95B | $119.51B |
Dividend Yield | 3.49% | 0.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
Sony trades at $20.80, up 0.58% on the day, with a bearish technical signal despite recent earnings beats. The company reported strong operating cash flow of $2.32 trillion in 2025, but faces a projected net loss in 2026. Analyst consensus is bullish with 68.75% buy ratings, while recent news highlights Sony's strategic shift to digital-only PlayStation games by 2028.
The outlook is mixed: strong cash flow and analyst support provide upside potential, but 2026's projected loss and bearish technicals pose near-term risks. Investors should weigh the digital transition's long-term benefits against execution challenges and market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Sony Group Corp
Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is a global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with six major business segments. The company fully consolidated Sony Financial in September 2020, which provides life and non-life insurance, banking, and other financial services.
Read more on SONY →
